Inflammation and Non-Culprit Lesion Progression in Heart Disease
Author Information
Author(s): Yilu Zhou, Zhanglong Wang, Fanke Huang, Jing Guan, Yue Wang, Yuwen Chen, Bingqing Li, Jianfeng Lv
Primary Institution: Medical College, China Three Gorges University
Hypothesis
The study investigates the association between immune-inflammatory indices (SII, SIRI, and PIV) and the progression of non-culprit coronary lesions in patients with acute coronary syndrome after percutaneous coronary intervention.
Conclusion
Higher levels of SII, SIRI, and PIV are associated with the progression of non-culprit coronary lesions in patients with acute coronary syndrome.
Supporting Evidence
- SII, SIRI, and PIV levels were significantly higher in the NCL progression group than in the non-progression group.
- Logistic regression analysis showed that SII, SIRI, and PIV were independent risk factors for NCL progression.
- ROC analysis indicated that SII had the highest sensitivity and specificity for predicting NCL progression.
Takeaway
This study found that certain blood markers related to inflammation can help predict if heart problems will get worse in patients after treatment.
Methodology
A retrospective analysis of patients with acute coronary syndrome who underwent percutaneous coronary intervention, with clinical and angiographic features collected from medical records.
Potential Biases
Potential biases due to the retrospective nature of the study and the single-center design.
Limitations
The study is a single-center retrospective analysis with a relatively small sample size and lacks detailed vascular imaging data.
Participant Demographics
The study included 311 patients with acute coronary syndrome, with a majority being male (approximately 74%).
Statistical Information
P-Value
P<0.001
Confidence Interval
95% CI: 0.6711–0.7865
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website